(S1 (S (NP (NN NF-kappaB) (NN Activation))))
(S1 (S (S (NP (NP (NN NF-kappaB) (NN binding) (NN activity)) (PP (IN in) (NP (JJ nuclear) (NNS extracts)))) (VP (VBD was) (VP (VBN determined) (S (VP (VBG using) (NP (NP (DT an) (JJ ELISA-based) (NN kit)) (PRN (-LRB- -LRB-) (NP (NP (NN Trans-AM) (NN p65)) (, ,) (NP (JJ Active) (NN Motif)) (, ,) (NP (NNP Rixensart) (, ,) (NNP Belgium))) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (JJ brief))) (, ,) (NP (NP (CD 5) (NN microg)) (PP (IN of) (NP (JJ nuclear) (NNS extracts)))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (DT a) (NN plate)) (VP (VBN coated) (PP (IN with) (NP (DT an) (NN NF-kappaB) (NN consensus) (NN oligonucleotide))))))))) (. .)))
(S1 (S (S (NP (NNS Plates)) (VP (VBD were) (VP (VBN washed) (PP (IN before) (NP (NP (NN addition)) (PP (IN of) (NP (DT an) (JJ anti-p65) (NN antibody)))))))) (. .)))
(S1 (S (S (NP (NN Antibody) (NN binding)) (VP (VBD was) (VP (VP (VBN detected) (PP (IN with) (NP (DT a) (JJ secondary) (JJ HRP-conjugated) (NN antibody)))) (CC and) (VP (VBN developed) (PP (IN with) (NP (NN TMB) (NN substrate))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN intensity)) (PP (IN of) (NP (DT the) (NN reaction)))) (VP (VBD was) (VP (VBN measured) (PP (IN at) (NP (CD 450) (NN nm)))))) (. .)))
